3.71
price up icon0.00%   0.00
 
loading
Nuvation Bio Inc stock is traded at $3.71, with a volume of 7.07M. It is up +0.00% in the last 24 hours and up +17.78% over the past month. Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
See More
Previous Close:
$3.71
Open:
$3.75
24h Volume:
7.07M
Relative Volume:
1.21
Market Cap:
$1.27B
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-10.60
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
+15.94%
1M Performance:
+17.78%
6M Performance:
+123.49%
1Y Performance:
+58.55%
1-Day Range:
Value
$3.665
$3.85
1-Week Range:
Value
$3.15
$3.95
52-Week Range:
Value
$1.54
$4.0899

Nuvation Bio Inc Stock (NUVB) Company Profile

Name
Name
Nuvation Bio Inc
Name
Phone
(415) 754-3517
Name
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Name
Employee
278
Name
Twitter
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
NUVB's Discussions on Twitter

Compare NUVB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NUVB
Nuvation Bio Inc
3.71 1.27B 0 -75.80M -68.07M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
403.30 104.83B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.00 63.59B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.35 60.43B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
800.00 48.45B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
343.87 37.91B 4.56B -176.77M 225.30M -1.7177

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-30-25 Initiated Jefferies Buy
Apr-23-25 Initiated Citizens JMP Mkt Outperform
Mar-27-24 Upgrade Jefferies Hold → Buy
Mar-26-24 Upgrade BTIG Research Neutral → Buy
Jan-06-23 Downgrade Jefferies Buy → Hold
Aug-02-22 Downgrade BMO Capital Markets Outperform → Market Perform
Aug-02-22 Downgrade BTIG Research Buy → Neutral
May-04-22 Initiated H.C. Wainwright Buy
Oct-15-21 Resumed BTIG Research Buy
Apr-06-21 Initiated RBC Capital Mkts Outperform
Mar-08-21 Initiated BMO Capital Markets Outperform
Mar-08-21 Initiated BTIG Research Buy
Mar-08-21 Initiated Cowen Outperform
Mar-08-21 Initiated Jefferies Buy
Mar-08-21 Initiated Wedbush Outperform
View All

Nuvation Bio Inc Stock (NUVB) Latest News

pulisher
Oct 03, 2025

Is Nuvation Bio Inc. Warrants stock undervalued after correctionMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can Nuvation Bio Inc. Class stock resist broad market declinesMarket Activity Report & Safe Entry Momentum Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Nuvation Bio Inc. stock resilient to inflationWeekly Stock Report & Fast Gaining Stock Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Nuvation Bio Inc. Class stock top growth indexesBond Market & Capital Efficient Trading Techniques - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Nuvation Bio Inc. reversing from oversold territoryJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Nuvation Bio Inc. Warrants stock sustain uptrend momentumMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Custom watchlist performance reports with Nuvation Bio Inc.Earnings Growth Summary & Stepwise Swing Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How big funds are accumulating Nuvation Bio Inc. Warrants stockGlobal Markets & Technical Buy Zone Confirmations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Nuvation Bio Inc. stock retracement – recovery analysis2025 Risk Factors & Daily Profit Maximizing Tips - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

How Nuvation Bio Inc. Class stock moves in volatile trading sessionsOptions Play & Real-Time Volume Trigger Notifications - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Will Nuvation Bio Inc. stock continue dividend increasesMarket Growth Review & Low Drawdown Investment Ideas - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

How moving averages guide Nuvation Bio Inc. tradingMarket Growth Summary & Free Fast Gain Swing Trade Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Assessing Nuvation Bio (NUVB) Valuation After Recent Share Price Momentum in the Biotech Sector - Yahoo

Oct 02, 2025
pulisher
Oct 01, 2025

Nuvation Bio Hits Day High with 15.63% Surge in Strong Intraday Performance - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

Multi factor analysis applied to Nuvation Bio Inc.Market Movers & Accurate Intraday Trade Tips - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Nuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer Treatment - MSN

Oct 01, 2025
pulisher
Sep 30, 2025

Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Investing News Network

Sep 30, 2025
pulisher
Sep 30, 2025

Jefferies initiates Nuvation Bio stock with Buy rating, $10 price target - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 30, 2025

Why Nuvation Bio Stock Is Skyrocketing Today - Mitrade

Sep 30, 2025
pulisher
Sep 30, 2025

Nuvation Bio Shares Rise After First Patient Enrolled in Phase 3 Lung Cancer Drug Trial - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

Nuvation issues trial update as Jefferies says buy (NUVB) - Seeking Alpha

Sep 30, 2025
pulisher
Sep 30, 2025

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday - Benzinga

Sep 30, 2025
pulisher
Sep 30, 2025

Jefferies Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

Nuvation Bio enrolls first patient in phase 3 lung cancer trial - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Business Wire

Sep 30, 2025
pulisher
Sep 30, 2025

What market sentiment indicators show for Nuvation Bio Inc. Class stockProduct Launch & Low Risk Investment Opportunities - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha

Sep 29, 2025
pulisher
Sep 29, 2025

Will breakout in Nuvation Bio Inc. lead to full recoveryMarket Weekly Review & Verified Entry Point Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Why Nuvation Bio Inc. stock is popular among millennials2025 Valuation Update & High Accuracy Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer - StocksToTrade

Sep 28, 2025
pulisher
Sep 28, 2025

Nuvation Bio (NUVB) Surges Amid Major Regulatory Milestone in Japan - timothysykes.com

Sep 28, 2025
pulisher
Sep 28, 2025

What analysts say about Nuvation Bio Inc stockMorning Star Patterns & Discover Strategies with Fellow Traders - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer - StocksToTrade

Sep 27, 2025
pulisher
Sep 26, 2025

Nuvation Bio Stock Hits Day Low of $3.00 Amid Price Pressure - Markets Mojo

Sep 26, 2025
pulisher
Sep 26, 2025

Nuvation Bio (NYSE:NUVB) Stock Price Up 7.2%Here's Why - MarketBeat

Sep 26, 2025

Nuvation Bio Inc Stock (NUVB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.43
price up icon 2.68%
$86.85
price up icon 0.66%
$33.56
price up icon 4.48%
$105.49
price up icon 0.94%
$157.16
price up icon 2.85%
biotechnology ONC
$343.87
price down icon 0.38%
Cap:     |  Volume (24h):